These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 36308365

  • 21. Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples.
    Sharma P, Gupta P, Gupta N, Suri V, Rajwanshi A.
    Turk Patoloji Derg; 2021; 37(1):32-38. PubMed ID: 33372263
    [Abstract] [Full Text] [Related]

  • 22. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus.
    Longatto Filho A, Utagawa ML, Shirata NK, Pereira SM, Namiyama GM, Kanamura CT, Santos Gda C, de Oliveira MA, Wakamatsu A, Nonogaki S, Roteli-Martins C, di Loreto C, Mattosinho de Castro Ferraz Mda G, Maeda MY, Alves VA, Syrjänen K.
    Int J Gynecol Pathol; 2005 Apr; 24(2):118-24. PubMed ID: 15782067
    [Abstract] [Full Text] [Related]

  • 23. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

  • 24. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
    Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G, New Technologies for Cervical Cancer Screening Working Group.
    Int J Cancer; 2020 Oct 01; 147(7):1864-1873. PubMed ID: 32170961
    [Abstract] [Full Text] [Related]

  • 25. Human Papillomavirus Detection and Abnormal Anal Cytology in HIV-infected Patients Using p16/Ki-67 Dual-Staining.
    Patarapadungkit N, Khonhan P, Pisuttimarn P, Pientong C, Ekalaksananan T, Koonmee S.
    Asian Pac J Cancer Prev; 2020 Jul 01; 21(7):2013-2019. PubMed ID: 32711427
    [Abstract] [Full Text] [Related]

  • 26. CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.
    Loghavi S, Walts AE, Bose S.
    Diagn Cytopathol; 2013 Jul 01; 41(7):582-7. PubMed ID: 22833355
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
    Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL.
    Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033
    [Abstract] [Full Text] [Related]

  • 28. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X, Liao G, Sun L, Zhang Y, Chen W, Qiao YL.
    Cancer Prev Res (Phila); 2020 Feb 19; 13(2):163-172. PubMed ID: 31871224
    [Abstract] [Full Text] [Related]

  • 29. Optimization of HPV-positive women triage with p16/Ki67 dual staining cytology in an organized cervical cancer screening program in the center region of Portugal.
    Sepodes B, Rebelo T, Santos F, Oliveira D, Catalão C, Águas F, Fernandes G.
    Eur J Obstet Gynecol Reprod Biol; 2024 Nov 19; 302():111-115. PubMed ID: 39244854
    [Abstract] [Full Text] [Related]

  • 30. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
    Zhang R, Ge X, You K, Guo Y, Guo H, Wang Y, Geng L.
    J Obstet Gynaecol Res; 2018 Nov 19; 44(11):2077-2084. PubMed ID: 30094887
    [Abstract] [Full Text] [Related]

  • 31. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 32. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, Endo S, Nagai K, Oki A, Ochi H, Morishita Y, Noguchi M, Yoshikawa H.
    Int J Clin Oncol; 2015 Oct 23; 20(5):974-81. PubMed ID: 25652908
    [Abstract] [Full Text] [Related]

  • 33. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
    Koo YJ, Hahn HS, Lee IH, Lim KT, Lee KH, Kim HS, Kim TJ, Chun YK, Kim HS, Hong SR.
    Virchows Arch; 2013 Nov 23; 463(5):689-96. PubMed ID: 24081504
    [Abstract] [Full Text] [Related]

  • 34. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
    Toll AD, Kelly D, Maleki Z.
    Diagn Cytopathol; 2014 Jul 23; 42(7):576-81. PubMed ID: 24288264
    [Abstract] [Full Text] [Related]

  • 35. Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis.
    Chen CC, Huang LW, Bai CH, Lee CC.
    Ann Saudi Med; 2016 Jul 23; 36(4):245-51. PubMed ID: 27478909
    [Abstract] [Full Text] [Related]

  • 36. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
    Celewicz A, Celewicz M, Wężowska M, Chudecka-Głaz A, Menkiszak J, Urasińska E.
    Pol J Pathol; 2018 Jul 23; 69(1):42-47. PubMed ID: 29895125
    [Abstract] [Full Text] [Related]

  • 37. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
    Qian QP, Zhang X, Ding B, Jiang SW, Li ZM, Ren ML, Shen Y.
    Clin Chim Acta; 2018 Aug 23; 483():281-285. PubMed ID: 29758205
    [Abstract] [Full Text] [Related]

  • 38. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT, Dalen I, Hansen E, Loge JL, Dybdahl BM, Dirdal MB, Moltu P, Berland JM.
    Cancer Cytopathol; 2017 Apr 23; 125(4):283-291. PubMed ID: 27918650
    [Abstract] [Full Text] [Related]

  • 39. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358
    [Abstract] [Full Text] [Related]

  • 40. Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital.
    Lertvutivivat S, Chanthasenanont A, Chanthasenanont A, Muangto T, Nanthakomon T, Pongrojpaw D, Bhamarapravatana K, Suwannarurk K.
    Asian Pac J Cancer Prev; 2016 May 15; 17(9):4353-4356. PubMed ID: 27797243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.